Serum selenium is low in newly diagnosed Graves' disease: A population-based study

Clinical Endocrinology

Volumn 79, Issue 4, 2013, Pages 584-590

  Bülow Pedersen, Inge ^a   Knudsen, Nils ^b   Carlé, Allan ^a   Schomburg, Lutz ^c   Köhrle, Josef ^c   Jørgensen, Torben ^d,e   Rasmussen, Lone Banke ^f,g   Ovesen, Lars ^h   Laurberg, Peter ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f AALBORG UNIVERSITY   (Denmark)

^g TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^h SLAGELSE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTRIX; SELENIUM; THYROID PEROXIDASE ANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DENMARK; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SELENIUM DEFICIENCY; SMOKING;

ADULT; DENMARK; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; SELENIUM; THYROID HORMONES;

EID: 84883499902     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12185     Document Type: Article

References (42)

1. Prummel, M.F., Strieder, T., &, Wiersinga, W.M., (2004) The environment and autoimmune thyroid diseases. European Journal of Endocrinology, 150, 605-618.
2. Kryukov, G.V., Castellano, S., Novoselov, S.V., et al,. (2003) Characterization of mammalian selenoproteomes. Science, 300, 1439-1443.
3. Contempre, B., Dumont, J.E., Denef, J.F., et al,. (1995) Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism. European Journal of Endocrinology, 133, 99-109.
4. Chiu-Ugalde, J., Wirth, E.K., Klein, M.O., et al,. (2012) Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxidants & Redox Signaling, 17, 902-913.
5. Derumeaux, H., Valeix, P., Castetbon, K., et al,. (2003) Association of selenium with thyroid volume and echostructure in 35 to 60-year-old French adults. European Journal of Endocrinology, 148, 309-315.
6. Köhrle, J., &, Gartner, R., (2009) Selenium and thyroid. Best Practice & Research Clinical Endocrinology & Metabolism, 23, 815-827.
7. Rasmussen, L.B., Hollenbach, B., Laurberg, P., et al,. (2009) Serum selenium and selenoprotein P status in adult Danes 8-year follow-up. Journal of Trace Elements in Medicine & Biology, 23, 265-271.
8. Bulow Pedersen, I., Knudsen, N., Jorgensen, T., et al,. (2002) Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. The Journal of Clinical Endocrinology & Metabolism, 87, 4462-4469.
9. Carle, A., Laurberg, P., Pedersen, I.B., et al,. (2006) Epidemiology of subtypes of hypothyroidism in Denmark. European Journal of Endocrinology, 154, 21-28.
10. Carle, A., Pedersen, I.B., Knudsen, N., et al,. (2011) Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. European Journal of Endocrinology, 164, 801-809.
11. Bulow Pedersen, I., Knudsen, N., Carle, A., et al,. (2011) A cautious iodization program bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. Clinical Endocrinology, 75, 120-126.
12. Pedersen, I.B., Knudsen, N., Jorgensen, T., et al,. (2003) Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clinical Endocrinology, 58, 36-42.
13. Schomburg, L., Schweizer, U., Holtmann, B., et al,. (2003) Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochemical Journal, 370, 397-402.
14. Raber, W., Gessl, A., Nowotny, P., et al,. (2002) Thyroid ultrasound versus antithyroid peroxidase antibody determination: a cohort study of four hundred fifty-one subjects. Thyroid, 2, 725-731.
15. Pedersen, O.M., Aardal, N.P., Larssen, T.B., et al,. (2000) The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid, 10, 251-259.
16. Duntas, L.H., (2008) Environmental factors and autoimmune thyroiditis. Nature Clinical Practice Endocrinology & Metabolism, 4, 454-460.
17. Kucharzewski, M., Braziewicz, J., Majewska, U., et al,. (2002) Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biological Trace Element Research, 88, 25-30.
18. Duntas, L.H., Mantzou, E., &, Koutras, D.A., (2003) Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. European Journal of Endocrinology, 148, 389-393.
19. Stoedter, M., Renko, K., Hog, A., et al,. (2010) Selenium controls the sex-specific immune response and selenoprotein expression during the acute-phase response in mice. Biochemical Journal, 429, 43-51.
20. Nichol, C., Herdman, J., Sattar, N., et al,. (1998) Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response? Clinical Chemistry, 44, 1764-1766.
21. Liu, C., Papewalis, C., Domberg, J., et al,. (2008) Chemokines and autoimmune thyroid disease. Hormones and Metabolic Research, 40, 361-368.
22. Rasmussen, L.B., Schomburg, L., Kohrle, J., et al,. (2011) Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. European Journal of Endocrinology, 164, 585-590.
23. Schomburg, L., (2011) Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nature Reviews Endocrinology, 8, 160-171.
24. Gartner, R., Gasnier, B.C., Dietrich, J.W., et al,. (2002) Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. The Journal of Clinical Endocrinology & Metabolism, 87, 1687-1691.
25. Mazokopakis, E.E., Papadakis, J.A., Papadomanolaki, M.G., et al,. (2007) Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto's thyroiditis. Thyroid, 17, 609-612.
26. Nacamulli, D., Mian, C., Petricca, D., et al,. (2010) Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clinical Endocrinology, 73, 535-539.
27. Toulis, K.A., Anastasilakis, A.D., Tzellos, T.G., et al,. (2010) Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis. Thyroid, 20, 163-1173.
28. Negro, R., Greco, G., Mangieri, T., et al,. (2007) The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. The Journal of Clinical Endocrinology & Metabolism, 92, 1263-1268.
29. Gartner, R., &, Gasnier, B.C., (2003) Selenium in the treatment of autoimmune thyroiditis. BioFactors, 19, 165-170.
30. Vrca, V.B., Skreb, F., Cepelak, I., et al,. (2004) Supplementation with antioxidants in the treatment of Graves′ disease; the effect on glutathione peroxidase activity and concentration of selenium. Clinica Chimica Acta, 341, 55-63.
31. Krysiak, R., &, Okopien, B., (2011) The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. The Journal of Clinical Endocrinology & Metabolism, 96, 2206-2215.
32. Burch, H.B., Lahiri, S., Bahn, R.S., et al,. (1997) Superoxide radical production stimulates retroocular fibroblast proliferation in Graves′ ophthalmopathy. Experimental Eye Research, 65, 311-316.
33. Marcocci, C., Kahaly, G.J., Krassas, G.E., et al,. (2011) Selenium and the course of mild Graves′ orbitopathy. The New England Journal of Medicine, 364, 1920-1931.
34. Karanikas, G., Schuetz, M., Kontur, S., et al,. (2008) No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid, 18, 7-12.
35. Bonfig, W., Gartner, R., &, Schmidt, H., (2010) Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. The Scientific World Journal, 10, 990-996.
36. Laclaustra, M., Navas-Acien, A., Stranges, S., et al,. (2009) Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environmental Health Perspectives, 117, 1409-1413.
37. Sheck, L., (2011) Selenium and the course of mild Graves′ orbitopathy. The New England Journal of Medicine, 365, 770-771.
38. Schomburg, L., &, Schweizer, U., (2009) Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochimica et Biophysica Acta, 1790, 1453-1462.
39. Rayman, M.P., (2000) The importance of selenium to human health. The Lancet, 356, 233-241.
40. Duntas, L.H., (2010) Selenium and the thyroid: a close-knit connection. Journal of Clinical Endocrinology & Metabolism, 95, 5180-5188.
41. Broome, C.S., McArdle, F., Kyle, J.A., et al,. (2004) An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. The American Journal of Clinical Nutrition, 80, 154-162.
42. Mittag, J., Behrends, T., Hoefig, C.S., et al,. (2010) Thyroid hormones regulate selenoprotein expression and selenium status in mice. PLoS ONE 5, e12931. www.plosone.org